Recently, a star revealed his experience of cutting a stomach polyp in a variety show, which quickly aroused heated discussions among the whole people and successfully dominated the hot search list. In the show, she revealed that her cancer screening index soared to 5 times the normal value during her physical examination, and after gastroscopy, it was found that there were 8 large polyps in the stomach and were removed, but the number of small polyps was too much, so she had no choice but to give up treatment. This news has once again brought gastrointestinal health issues into the focus of public attention.

In the fast-paced modern life, many people rely on their youth to squander their health, stay up late, overeat, and take out as a daily routine, and the gastrointestinal tract has long been overwhelmed. The data shows that the incidence of gastrointestinal diseases in our country continues to rise and is getting younger and younger. Seemingly small polyps, if left unchecked, are likely to become a time bomb for health. Just like the experience of an artist, it is a wake-up call for everyone, even seemingly healthy young people cannot take their physical condition lightly.

Everyone knows that gastroenteroscopy is an important means of screening for gastrointestinal diseases, but it is invasive, and many people are afraid of gastrointestinal endoscopy because of fear of pain and psychological burden, thus missing the golden opportunity for early detection and treatment of diseases. Is there an easier and more convenient way to check? In fact, in addition to traditional gastroenteroscopy, there are also some advanced detection methods, such as the serum detection technology we are going to discuss today, which can be used as an auxiliary means of risk assessment.

Serological testing technology, as a non-invasive testing method, is gradually entering the public eye. It reflects the health of the gastrointestinal tract by detecting specific markers in the blood. Taking REG1A serum detection reagents as an example, its detection principle has a scientific basis. When the gastrointestinal mucosa is damaged, REG1A will be overexpressed and secreted into the blood, and its expression level in patients with gastrointestinal organic lesions, especially inflammatory bowel disease, gastrointestinal tumors and other diseases, is closely related to the severity and progression stage of the disease. In short, by detecting the content of REG1A in the blood, the health status of the gastrointestinal tract can be known in advance, providing reference clues for subsequent refined examinations.

This examination method has also helped many people detect health problems early in real life. For example, Mr. Li, who works in Shenzhen, had no obvious symptoms of digestive discomfort before, and after the REG1A test, he suggested that he needed to go to the hospital for further examination. Based on this tip, he went to the hospital to further improve the gastroenteroscopy, and finally found a tumor in the upper rectum and was pathologically diagnosed as adenoma, which is a clinically recognized type of precancerous lesion, with 50 polyps in the left half of the colon. Mr. Li later mentioned this experience and said that it was this testing method that did not require the pain of invasive examinations that allowed him to detect potential risks at the asymptomatic stage and bought valuable time for follow-up intervention.

Existing studies have shown that the combination of multiple markers can improve the early warning ability of early lesions. Research by Professor Wan Desen's team at Sun Yat-sen University Cancer Hospital has shown that when REG1A is combined with the traditional marker CEA to detect colorectal cancer, the sensitivity can reach 81.4%, the specificity can reach 92.8%, and the positive predictive value can reach 95.9%, providing effective help for further examination/treatment. In addition to colorectal cancer, REG1A serum detection reagents can also accurately detect and warn in advance for other gastrointestinal organic lesions, such as inflammatory bowel disease, gastric ulcers, etc.

In today's fast-paced life, health cannot wait, and gastrointestinal health assessment should be done as soon as possible. Serological testing, with non-invasive and accurate detection methods, escorts our gastrointestinal health. Don't turn a blind eye to the "distress signal" sent by the gastrointestinal tract, choose scientific and appropriate examination methods, take the initiative to check, find problems in time, and add a guarantee to your health.